Medication info
MT-Formin Tablet (Metformin Hydrochloride)

MT-Formin Tablet (Metformin Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
DongKuk Pharmaceutical Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
300 tablets/bottle
Approval status
Active

MFDS item code 201908588 · Approved 2019.12.23 · Insurance code 653404840

Summary

Main use
Treatment of type 2 diabetes
Who uses it
Adults · Children
Adult dosage
The dose should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medication must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into two doses, taken in the morning and evening. For doses exceeding 2000mg, administer in three divided doses with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess response to this medication and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medication, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in a patient whose blood glucose was previously controlled with diet alone, short-term administration of this medication may be sufficient to achieve an adequate effect. Patients with renal impairment This medication may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that could increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in two divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medication should be stopped immediately.
Children's dosage
Children aged 10 years or older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
DongKuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes

  • Type 2 Diabetes
View approved original text

This medication is used in patients with Type 2 diabetes whose blood sugar control is insufficient with diet and exercise, especially in overweight adult patients. It can be taken alone by adults or in combination with other oral hypoglycemic agents or insulin. In children aged 10 years and older and adolescents, it can also be used alone or in combination with insulin. This medication effectively improves blood sugar levels and aids in diabetes management.

Dosage and Administration

Adult dosage

The dose should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. Treatment with this medication must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into two doses, taken in the morning and evening. For doses exceeding 2000mg, administer in three divided doses with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess response to this medication and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this medication, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in a patient whose blood glucose was previously controlled with diet alone, short-term administration of this medication may be sufficient to achieve an adequate effect. Patients with renal impairment This medication may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that could increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in two divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medication should be stopped immediately.

Children's dosage

Children aged 10 years or older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause serious lactic acidosis or hypoglycemia, so caution is needed. It should not be administered to patients with moderately or severely impaired kidney function, dehydration, serious infections, or cardiovascular issues. Additionally, patients scheduled to undergo tests with iodinated contrast agents must discontinue this medication, and it can only be resumed after kidney function has returned to normal. It is also contraindicated in patients who have had allergic reactions to this medication or similar drugs, patients with Type 1 diabetes, and those with acute or chronic metabolic acidosis. Patients with severe infections or trauma should stop taking it until they can resume oral intake, and it should be temporarily discontinued 48 hours prior to surgery. Patients with liver impairment, severe pulmonary dysfunction, and those who consume excessive alcohol should also use caution with this medication. Patients with irregular meals or engaging in intense exercise, as well as those who may have drug interactions, should be administered this medication cautiously. Lactic acidosis is rare but can be fatal; symptoms such as muscle pain, weakness, difficulty breathing, and abdominal pain should prompt immediate medical attention. Gastrointestinal symptoms are common at the start of treatment but are usually temporary and can be alleviated by taking the medication with meals. This medication is primarily excreted through the kidneys, so kidney function should be monitored regularly, and treatment should be discontinued if kidney function declines. Alcohol can increase the risk of side effects associated with this medication, so excessive alcohol consumption should be avoided. During pregnancy, fetal growth and health should be closely monitored, and the use of this drug is not recommended while breastfeeding. Elderly patients often experience decreased kidney function and thus require dosage adjustments and monitoring. This medication may interact with other hypoglycemic agents or multiple medications, so it is important to inform your doctor or pharmacist of all medications being taken. In cases of overdose, blood dialysis can be used to remove this medication, and patients should seek medical attention immediately. This medication does not cause weight gain and may actually help with weight maintenance or loss. It can be used in children and adolescents, but growth and development should be monitored closely. This medication should be kept out of reach of children and should not be transferred to another container.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its effectiveness and prevent degradation.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.